Blockchain Registration Transaction Record

HeartBeam Completes Heart Attack Detection Study Ahead of Schedule

HeartBeam (BEAT) completes ALIGN-ACS pilot study enrollment ahead of schedule for heart attack detection using 3D ECG technology. Results may support FDA submission and expanded indication.

This news matters because heart attacks are a leading cause of death worldwide, and early detection is critical for survival. The HeartBeam System, with its portable 3D ECG technology, has the potential to revolutionize cardiac care by enabling patients to receive timely diagnosis outside of medical facilities. If successful, this could reduce delays in treatment, improve outcomes, and lower healthcare costs. The accelerated enrollment signals strong interest and potential for faster regulatory approval, bringing this life-saving technology closer to patients.